Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Researchers develop program that can spot falsified radiology reports written by AI
“With generative AI becoming more capable of producing remarkably convincing radiology reports, there’s a greater risk of fabricated reports being used to falsify medical histories and support fraudulent claims,” the team cautioned.
Trump’s EPA wants to roll back Biden-era pollution limits for medical device sterilization
Ethylene oxide is an odorless gas used to sterilize pacemakers, leads, stents and many other medical devices. Long-term exposure, however, can cause cancer. The Biden administration made it a priority to reduce ethylene oxide emissions, but many critics thought those cuts were too extreme.
New obesity statistics highlight importance of preventive cardiology
Cardiovascular health is much worse in some parts of the United States than others. Cardiologists in those high-risk areas can make a world of difference by embracing preventive cardiology and working to treat patients before it is too late.
Imaging evaluations and PCI planning: Heartflow announces ‘tremendous progress’ for AI portfolio
Heartflow's AI technologies are at the center of multiple ACC.26 presentations. In addition, the company announced, the first patient was enrolled into the NAVIGATE-PCI registry.
Heart failure hospitalizations after PCI: a warning sign of ‘exceptionally high risk’
Nonfatal adverse events after PCI are associated with an increased risk of two-year mortality. That risk is especially high, it seems, when patients are hospitalized for heart failure symptoms such as shortness of breath and edema.

The risks, benefits of polypharmacy after MI for frail nursing home residents

Nursing home residents who were prescribed three or four preventive medications after myocardial infarction (MI) were 26% less likely to die within 90 days than those prescribed only one drug, researchers reported April 9 in Circulation: Cardiovascular Quality and Outcomes.

Comic illustrations enhance informed consent before coronary angiography

A new pilot study out of Germany suggests a comic-style graphic supplement can improve the informed consent process before coronary angiography by putting patients at ease and helping them understand the procedure.

Socioeconomic factors may impact the chances of getting an LVAD

A study of nearly 900,000 patients with heart failure or cardiogenic shock revealed their race, insurance coverage and ZIP code were associated with their odds of receiving a left ventricular assist device (LVAD).

Medtronic, Blue Cross ink outcomes-based agreement for glucose monitor

Medtronic has struck a value-based agreement with Blue Cross and Blue Shield of Minnesota in which the medical device company will pay back the insurer if patients using the Guardian Connect continuous glucose monitoring (CGM) system fail to keep their blood sugar levels within a specified range.

Real-world Watchman results hold up at 2 years

Left atrial appendage (LAA) closure with the Watchman device was associated with low rates of stroke and bleeding events in high-risk atrial fibrillation patients over a two-year follow-up period, according to a real-world analysis published April 3 in Circulation: Electrophysiology and Arrhythmia.

Genetic variants may guard against heart disease

Rare protein-truncating variants in the apolipoprotein B (APOB) gene are linked to lower triglycerides and LDL cholesterol levels and also appear to be protective against coronary heart disease (CHD), according to a study published in Circulation: Genomic and Precision Medicine.

Registry analysis finds link between TAVR volume, mortality

With CMS just months away from an updated national coverage determination for transcatheter aortic valve replacement (TAVR), a new analysis in the New England Journal of Medicine suggests the relationship between procedural volume and TAVR outcomes remains important in the United States.

FDA approves therapy to reduce infarct size in LAD STEMI after PCI

Once the artery has been opened with PCI, the treatment involves mixing a patient’s own blood with oxygenated saline and then infusing that superoxygenated mixture to the targeted ischemic area for 60 minutes.

Clinical

Researchers develop program that can spot falsified radiology reports written by AI

Trump’s EPA wants to roll back Biden-era pollution limits for medical device sterilization

New obesity statistics highlight importance of preventive cardiology

Imaging evaluations and PCI planning: Heartflow announces ‘tremendous progress’ for AI portfolio

Heart failure hospitalizations after PCI: a warning sign of ‘exceptionally high risk’